Silver Book Fact

An Alzheimer’s disease research study showed that billions of dollars could be saved if physicians could intervene before someone becomes symptomatic. This positive net savings occurred with both drug treatment and caregiver-support programs; the greatest benefits with a combination of both.

Weimer, David L, and Mark A Sager. Early Identification and Treatment of Alzheimer’s Disease: Social and fiscal outcomes. Alzheimers Dement. 2009; 5(3): 215-26. http://www.alzheimersanddementia.com/article/S1552-5260(09)00029-6/abstract

Reference

Title
Early Identification and Treatment of Alzheimer’s Disease: Social and fiscal outcomes
Publication
Alzheimers Dement
Publication Date
2009
Authors
Weimer, David L, and Mark A Sager
Volume & Issue
Volume 5, Issue 3
Pages
215-26
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Current research supported by the National Institute of Neurological Disease Orders and Stroke (NINDS) at NIH is using animal models to study progression of the disease and develop new drugs…  
  • Use of existing or new drugs/compounds for Alzheimer’s prevention could result in a delay of onset of between 2 and 5 years.  
  • Research breakthroughs that slow the onset and progression of Alzheimer’s disease could achieve annual Medicare savings of $51 billion by 2015, $126 billion by 2025, and $444 billion by 2050.  
  • According to the Pharmaceutical Research and Manufacturers of America, every $1 spent on Alzheimer’s research would save Medicare $10 by 2015 and $25 by 2025.  
  • Deep Brain Stimulation for Parkinson’s Adds QALYs and Saves Money